# A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

> **NCT00931476** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 86 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency
- Healthy

## Interventions

- **DRUG:** somatropin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00931476
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04-06
- **Primary completion:** 2000-06-08
- **Final completion:** 2000-06-08
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931476, "A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00931476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*